Background illustration for clinical trials search

Paid Clinical Trials Memphis

Discover 533 paid clinical trials in Memphis, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

for
Ulcerative Colitis, Obesity or Overweight
Location: Cordova TN, St Louis MO, Shreveport LA, New Albany IN,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70

Code: NCT06937086

Phase 3, Recruiting

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

for
Crohn's Disease, Obesity or Overweight
Location: Cordova TN, St Louis MO, Shreveport LA, New Albany IN,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70

Code: NCT06937099

Phase 3, Recruiting

Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

for
Kidney Disease, End-Stage, End-stage Renal Disease,
Location: Memphis TN, Chattanooga TN, Dallas TX, Houston TX,
Sponsor: C. R. Bard

Sex: All

Age: 18+

Code: NCT04634916

Recruiting

Evaluation of the Optimal Transition Program

for
ESRD, Hemodialysis
Location: Memphis TN, Sacramento CA, Oakland CA
Sponsor: Satellite Healthcare

Sex: All

Age: 18+

Code: NCT04263233

Recruiting

Cooperative Huntington's Observational Research Trial

for
Huntington Disease
Location: Memphis TN, St. Louis MO, Louisville KY, Atlanta GA,
Sponsor: HP Therapeutics Foundation

Sex: All

Age: 0+

Code: NCT00313495

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer
Location: Memphis TN, Little Rock AR, Nashville TN,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT05061550

Phase 2, Recruiting

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

for
Systemic Lupus Erythematosus
Location: Memphis TN, New Albany IN, Oklahoma City OK,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70

Code: NCT07430306

Phase 3, Recruiting

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

for
Non-small Cell Lung Cancer (NSCLC)
Location: Memphis TN, Bridgeton MO, Louisville KY, Newnan GA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07291037

Phase 3, Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for
Cardiovascular Disease
Location: Memphis TN, Little Rock AR, Paducah KY, Athens AL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase 3, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: Memphis TN, Tupelo MS, North Little Rock AR,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase 3, Recruiting

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

for
Heart Failure and Impaired Kidney Function
Location: Memphis TN, Jackson TN, Little Rock AR, Nashville TN,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06307652

Phase 3, Recruiting

A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia

for
Dystonia
Location: Memphis TN, Nashville TN, Birmingham AL, St Louis MO,
Sponsor: Vima Therapeutics

Sex: All

Age: 18 - 70

Code: NCT07304089

Phase 2, Recruiting

A Study of Buntanetap in Participants With PD

for
Parkinson's Disease (PD), Deep Brain Stimulation
Location: Memphis TN, Cordova TN, Birmingham AL, Tulsa OK,
Sponsor: Annovis Bio Inc.

Sex: All

Age: 40 - 70+

Code: NCT07284784

Phase 2, Phase 3, Recruiting

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

for
Atrial Fibrillation (AF)
Location: Memphis TN, West Monroe LA, Birmingham AL,
Sponsor: Anthos Therapeutics, Inc.

Sex: All

Age: 65+

Code: NCT05712200

Phase 3, Recruiting

Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia

for
Relapsed Myelodysplastic Syndrome,
Location: Memphis TN, Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT06399640

Phase 1, Recruiting

Telescope Exchange Study

for
Age-related Macular Degeneration
Location: Memphis TN, Springfield MO, Fort Worth TX, Ann Arbor MI,
Sponsor: VisionCare, Inc.

Sex: All

Age: 65+

Code: NCT03011554

Recruiting

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

for
Non-muscle Invasive Bladder Cancer
Location: Memphis TN, Little Rock AR, Nashville TN, Homewood AL,
Sponsor: Protara Therapeutics

Sex: All

Age: 18+

Code: NCT05951179

Phase 2, Recruiting
New

Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Memphis TN, Collierville TN, Jonesboro AR, Oxford MS,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT07578116

Phase 3, Recruiting

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

for
Non-Small Cell Lung Cancer, NSCLC,
Location: Memphis TN, Nashville TN, Irving TX, Houston TX,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06162221

Phase 1, Phase 2, Recruiting

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

for
Brain Cancer, Breast Cancer, Bladder Cancer, Cervical Cancer,
Location: Memphis TN, Nashville TN, Elizabethtown KY,
Sponsor: Adela, Inc

Sex: All

Age: 40+

Code: NCT05366881

Recruiting